Clinical Trial Update: Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating metabolism and excretion of HSK21542 in maintenance hemodialysis patients with chronic kidney disease, conducted by Haisco Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• HSK21542

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Chronic Kidney Disease Patients | Phase 1 | Status: COMPLETED